HGEN logo

Humanigen (HGEN) EBITDA

Annual EBITDA

-$67.81 M
+$166.57 M+71.07%

December 31, 2022

Summary

Performance

1-Year Change

+71.07%

3-Year Change

-658.1%

5-Year Change

-259.12%

15-Year Change

-259.12%

HGEN EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$1.64 M

3-Year Low

-$234.38 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
HGEN previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
HGEN next annual earnings announcement has not yet been scheduled

OtherHGENprofitabilitymetrics:

Annual Revenue

$2.51 M
HGEN annual revenue is $2.51 million

Annual Net Income

-$70.73 M
HGEN annual net profit is -$70.73 million

Annual EBIT

-$67.81 M
HGEN annual earnings before interest & taxes is -$67.81 million

Annual EPS

-$0.79
HGEN annual earnings per share is -$0.79

Quarterly EBITDA

-$4.16 M
-$8.67 M-192.37%

March 31, 2023

Summary

Performance

3-Month Change

-192.37%

1-Year Change

+79.73%

3-Year Change

-102.43%

5-Year Change

+11.08%

HGEN Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$4.51 M
HGEN quarterly EBITDA is currently -192.37% below its historical high of $4.51 million

3-Year Low

-$32.79 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
HGEN previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
HGEN next earnings announcement has not yet been scheduled

OtherHGENprofitabilitymetrics:

Quarterly Revenue

$221.00 K
HGEN quarterly revenue is $221.00 thousand

Quarterly Net Income

-$4.18 M
HGEN quarterly net profit is -$4.18 million

Quarterly EBIT

-$4.16 M
HGEN quarterly earnings before interest & taxes is -$4.16 million

Quarterly EPS

-$0.04
HGEN quarterly earnings per share is -$0.04

TTM EBITDA

-$51.43 M
+$16.38 M+24.16%

March 31, 2023

Summary

Performance

3-Month Change

+24.16%

1-Year Change

+72.84%

3-Year Change

-486.92%

5-Year Change

-474.98%

HGEN TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$273.00 K

3-Year Low

-$234.38 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
HGEN previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
HGEN next earnings announcement has not yet been scheduled

OtherHGENprofitabilitymetrics:

TTM Revenue

$1.70 M
HGEN TTM revenue is $1.70 million

TTM Net Income

-$53.63 M
HGEN TTM net profit is -$53.63 million

TTM EBIT

-$51.43 M
HGEN TTM earnings before interest & taxes is -$51.43 million

TTM EPS

-$0.54
HGEN TTM earnings per share is -$0.54

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$67.81 M
HGEN annual EBITDA is -$67.81 million

Annual Net Income

-$70.73 M
HGEN annual net profit is -$70.73 million

Annual Interest Expense

$2.92 M
HGEN annual interest expense is $2.92 million

Annual Income Tax

-
HGEN annual income tax value is unknown

Annual D&A

-
HGEN annual depreciation & amortization value is unknown

HGEN EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+71.1%+79.7%+72.8%
3 y3 years-658.1%-102.4%-486.9%
5 y5 years-259.1%+11.1%-475.0%

HGEN EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+245.6%-192.4%+687.5%at high+355.7%
5 y5-year+658.1%+245.6%-192.4%+1582.4%+486.9%+355.7%
alltimeall time+4042.5%+245.6%-192.4%+1582.4%>+9999.0%+355.7%

Humanigen EBITDA History

DateAnnualQuarterlyTTM
Mar 2023
-
-$4.16 M(-192.4%)
-$51.43 M(-24.2%)
Dec 2022
-$67.81 M(-71.1%)
$4.51 M(-120.1%)
-$67.81 M(-35.5%)
Sep 2022
-
-$22.39 M(-23.8%)
-$105.11 M(-29.3%)
Jun 2022
-
-$29.38 M(+43.0%)
-$148.71 M(-21.5%)
Mar 2022
-
-$20.54 M(-37.4%)
-$189.38 M(-19.2%)
Dec 2021
-$234.38 M(+165.7%)
-$32.79 M(-50.3%)
-$234.38 M(+0.2%)
Sep 2021
-
-$65.99 M(-5.8%)
-$233.89 M(+17.7%)
Jun 2021
-
-$70.06 M(+6.9%)
-$198.65 M(+31.0%)
Mar 2021
-
-$65.55 M(+103.0%)
-$151.69 M(+72.0%)
Dec 2020
-$88.20 M(+886.0%)
-$32.30 M(+5.0%)
-$88.20 M(+53.2%)
Sep 2020
-
-$30.75 M(+33.1%)
-$57.58 M(+99.4%)
Jun 2020
-
-$23.10 M(+1022.9%)
-$28.88 M(+229.6%)
Mar 2020
-
-$2.06 M(+22.4%)
-$8.76 M(-2.0%)
Dec 2019
-$8.95 M(-19.7%)
-$1.68 M(-17.9%)
-$8.95 M(-0.9%)
Sep 2019
-
-$2.05 M(-31.3%)
-$9.03 M(-0.2%)
Jun 2019
-
-$2.98 M(+33.1%)
-$9.04 M(+4.1%)
Mar 2019
-
-$2.24 M(+27.0%)
-$8.69 M(-22.0%)
Dec 2018
-$11.13 M(-41.0%)
-$1.76 M(-14.4%)
-$11.13 M(-4.4%)
Sep 2018
-
-$2.06 M(-21.6%)
-$11.65 M(-24.8%)
Jun 2018
-
-$2.63 M(-43.9%)
-$15.49 M(-15.4%)
Mar 2018
-
-$4.68 M(+105.5%)
-$18.32 M(-3.0%)
Dec 2017
-$18.88 M(-29.5%)
-$2.28 M(-61.4%)
-$18.88 M(-12.5%)
Sep 2017
-
-$5.91 M(+8.2%)
-$21.59 M(+7.1%)
Jun 2017
-
-$5.46 M(+4.1%)
-$20.15 M(-24.3%)
Mar 2017
-
-$5.24 M(+5.2%)
-$26.64 M(-0.6%)
DateAnnualQuarterlyTTM
Dec 2016
-$26.79 M(-22.0%)
-$4.98 M(+11.5%)
-$26.79 M(-23.0%)
Sep 2016
-
-$4.47 M(-62.6%)
-$34.78 M(-5.1%)
Jun 2016
-
-$11.94 M(+121.4%)
-$36.63 M(+20.4%)
Mar 2016
-
-$5.39 M(-58.4%)
-$30.44 M(-11.4%)
Dec 2015
-$34.34 M(-5.9%)
-$12.98 M(+105.2%)
-$34.34 M(+11.8%)
Sep 2015
-
-$6.32 M(+10.1%)
-$30.70 M(-4.3%)
Jun 2015
-
-$5.75 M(-38.2%)
-$32.07 M(-10.2%)
Mar 2015
-
-$9.29 M(-0.5%)
-$35.72 M(-2.1%)
Dec 2014
-$36.47 M(-10.1%)
-$9.34 M(+21.5%)
-$36.47 M(-1.4%)
Sep 2014
-
-$7.69 M(-18.1%)
-$36.98 M(-8.1%)
Jun 2014
-
-$9.39 M(-6.5%)
-$40.24 M(-5.0%)
Mar 2014
-
-$10.05 M(+2.0%)
-$42.37 M(+4.4%)
Dec 2013
-$40.56 M(+76.2%)
-$9.85 M(-10.0%)
-$40.59 M(-4.4%)
Sep 2013
-
-$10.95 M(-5.0%)
-$42.44 M(+6.9%)
Jun 2013
-
-$11.53 M(+39.4%)
-$39.72 M(+31.4%)
Mar 2013
-
-$8.27 M(-29.3%)
-$30.23 M(+31.3%)
Dec 2012
-$23.02 M(+1306.3%)
-$11.70 M(+42.3%)
-$23.02 M(+140.6%)
Sep 2012
-
-$8.22 M(+303.4%)
-$9.57 M(+338.7%)
Jun 2012
-
-$2.04 M(+91.9%)
-$2.18 M(+63.4%)
Mar 2012
-
-$1.06 M(-160.5%)
-$1.33 M(+389.0%)
Dec 2011
-$1.64 M(-69.0%)
$1.75 M(-310.1%)
-$273.00 K(-86.5%)
Sep 2011
-
-$835.00 K(-29.9%)
-$2.03 M(+70.1%)
Jun 2011
-
-$1.19 M
-$1.19 M
Dec 2010
-$5.28 M(-80.2%)
-
-
Dec 2009
-$26.62 M
-
-

FAQ

  • What is Humanigen annual EBITDA?
  • What is the all time high annual EBITDA for Humanigen?
  • What is Humanigen annual EBITDA year-on-year change?
  • What is Humanigen quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Humanigen?
  • What is Humanigen quarterly EBITDA year-on-year change?
  • What is Humanigen TTM EBITDA?
  • What is the all time high TTM EBITDA for Humanigen?
  • What is Humanigen TTM EBITDA year-on-year change?

What is Humanigen annual EBITDA?

The current annual EBITDA of HGEN is -$67.81 M

What is the all time high annual EBITDA for Humanigen?

Humanigen all-time high annual EBITDA is -$1.64 M

What is Humanigen annual EBITDA year-on-year change?

Over the past year, HGEN annual EBITDA has changed by +$166.57 M (+71.07%)

What is Humanigen quarterly EBITDA?

The current quarterly EBITDA of HGEN is -$4.16 M

What is the all time high quarterly EBITDA for Humanigen?

Humanigen all-time high quarterly EBITDA is $4.51 M

What is Humanigen quarterly EBITDA year-on-year change?

Over the past year, HGEN quarterly EBITDA has changed by +$16.38 M (+79.73%)

What is Humanigen TTM EBITDA?

The current TTM EBITDA of HGEN is -$51.43 M

What is the all time high TTM EBITDA for Humanigen?

Humanigen all-time high TTM EBITDA is -$273.00 K

What is Humanigen TTM EBITDA year-on-year change?

Over the past year, HGEN TTM EBITDA has changed by +$137.95 M (+72.84%)